Published in Am J Med on September 01, 1976
Successful use of broth microdilution in susceptibility tests for methicillin-resistant (heteroresistant) staphylococci. J Clin Microbiol (1983) 9.99
Methicillin resistance in staphylococci: molecular and biochemical basis and clinical implications. Clin Microbiol Rev (1997) 6.98
Methicillin-resistant staphylococci. Clin Microbiol Rev (1988) 3.77
Methicillin-resistant staphylococci: detection methods and treatment of infections. Antimicrob Agents Chemother (1989) 3.40
Retrospective study of the toxicity of preparations of vancomycin from 1974 to 1981. Antimicrob Agents Chemother (1983) 2.99
Methicillin-resistant Staphylococcus aureus susceptibility testing by an automated system, Autobac I. Antimicrob Agents Chemother (1978) 2.79
Interlaboratory variation of antibiograms of methicillin-resistant and methicillin-susceptible Staphylococcus aureus strains with conventional and commercial testing systems. J Clin Microbiol (1983) 2.11
Comparison of the activities of coumermycin, ciprofloxacin, teicoplanin, and other non-beta-lactam antibiotics against clinical isolates of methicillin-resistant Staphylococcus aureus from various geographical locations. Antimicrob Agents Chemother (1985) 2.02
Antimicrobial agent susceptibility patterns of bacteria in hospitals from 1971 to 1982. J Clin Microbiol (1984) 1.91
Analysis of plasmids in nosocomial strains of multiple-antibiotic-resistant Staphylococcus aureus. Antimicrob Agents Chemother (1983) 1.81
Role of beta-lactamase and different testing conditions in oxacillin-borderline-susceptible staphylococci. Antimicrob Agents Chemother (1988) 1.78
Comparative evaluation of daptomycin (LY146032) and vancomycin in the treatment of experimental methicillin-resistant Staphylococcus aureus osteomyelitis in rabbits. Antimicrob Agents Chemother (1989) 1.78
Environmental study of a methicillin-resistant Staphylococcus aureus epidemic in a burn unit. J Clin Microbiol (1983) 1.68
Cross-resistance between methicillin and cephalosporins for staphylococci: a general assumption not true for cefamandole. Antimicrob Agents Chemother (1984) 1.61
Detection of methicillin-resistant Staphylococcus epidermidis. J Clin Microbiol (1986) 1.60
Rapid extraction from and direct identification in clinical samples of methicillin-resistant staphylococci using the PCR. J Clin Microbiol (2000) 1.58
Disparity between timed-kill and checkerboard methods for determination of in vitro bactericidal interactions of vancomycin plus rifampin versus methicillin-susceptible and -resistant Staphylococcus aureus. Antimicrob Agents Chemother (1984) 1.57
Use of a heavy inoculum in the in vitro evaluation of the anti-staphylococcal activity of 19 cephalosporins. Antimicrob Agents Chemother (1978) 1.57
Rapid recognition of methicillin-resistant Staphylococcus aureus by use of automated test systems. J Clin Microbiol (1984) 1.47
Reevaluation of the ability of the standardized disk diffusion test to detect methicillin-resistant strains of Staphylococcus aureus. J Clin Microbiol (1984) 1.36
Clinical comparative study on the activity of cefamandole in the treatment of serious staphylococcal infections caused by methicillin-susceptible and methicillin-resistant strains. Antimicrob Agents Chemother (1986) 1.31
Phage pattern-specific oxacillin-resistant and borderline oxacillin-resistant Staphylococcus aureus in U.S. hospitals: epidemiological significance. J Clin Microbiol (1992) 1.25
Methicillin-resistant-Staphylococcus aureus colonization and infection in a rehabilitation facility. J Clin Microbiol (1982) 1.15
Methicillin-resistant strains of Staphylococcus aureus phage type 92. Antimicrob Agents Chemother (1979) 1.13
Evaluation of MicroScan rapid gram-positive panels for detection of oxacillin-resistant staphylococci. J Clin Microbiol (1994) 1.12
In vitro susceptibility patterns of methicillin-resistant and-susceptible Staphylococcus auerues strains in a population of parenteral drug abusers from 1972 to 1981. Antimicrob Agents Chemother (1983) 1.11
Comparison of a radioimmunoassay and a microbiological assay for measurement of serum vancomycin concentrations. Antimicrob Agents Chemother (1980) 1.10
Molecular epidemiology of clinical and carrier strains of methicillin resistant Staphylococcus aureus (MRSA) in the hospital settings of north India. Ann Clin Microbiol Antimicrob (2006) 1.07
Evaluation of MicroScan MIC panels for detection of oxacillin-resistant staphylococci. J Clin Microbiol (1988) 1.04
Methicillin-resistant Staphylococcus aureus in orthopaedic surgery. Int Orthop (2003) 1.03
Cephalosporin susceptibility of methicillin-resistant, coagulase-negative staphylococci. Antimicrob Agents Chemother (1987) 1.00
Activity of cephalosporins against methicillin-susceptible and methicillin-resistant, coagulase-negative staphylococci: minimal effect of beta-lactamase. Antimicrob Agents Chemother (1980) 0.99
Cefotaxime in combination with other antibiotics for the treatment of severe methicillin-resistant staphylococcal infections. Infection (1985) 0.98
Activity of ten cephalosporins on biomass of methicillin-susceptible and -resistant Staphylococcus aureus. Antimicrob Agents Chemother (1980) 0.98
Unusual susceptibility of methicillin-resistant Staphylococcus aureus to erythromycin, clindamycin, gentamicin, and tetracycline at 30 degrees C but not at 35 degrees C. J Clin Microbiol (1984) 0.96
Subinhibitory concentrations of imipenem induce increased resistance to methicillin and imipenem in vitro in methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother (1984) 0.96
Effect of rifampin and bacitracin on nasal carriers of Staphylococcus aureus. Antimicrob Agents Chemother (1984) 0.93
MRSA and the environment: implications for comprehensive control measures. Eur J Clin Microbiol Infect Dis (2008) 0.90
Efficacy of short courses of oral novobiocin-rifampin in eradicating carrier state of methicillin-resistant Staphylococcus aureus and in vitro killing studies of clinical isolates. Antimicrob Agents Chemother (1990) 0.88
Analysis of nosocomial outbreaks with multiply and methicillin-resistant Staphylococcus aureus (MRSA) in Germany: implications for hospital hygiene. Infection (1994) 0.87
Infections caused by multidrug resistant organisms are not associated with overall, all-cause mortality in the surgical intensive care unit: the 20,000 foot view. J Am Coll Surg (2012) 0.84
Design and surface immobilization of short anti-biofilm peptides. Acta Biomater (2016) 0.84
Bactericidal activity of oxacillin against beta-lactamase-hyperproducing Staphylococcus aureus. Antimicrob Agents Chemother (1988) 0.83
Quarantine, isolation, and cohorting: from cholera to Klebsiella. Surg Infect (Larchmt) (2012) 0.75
Prevalence and laboratory identification of methicillin-resistant Staphylococcus aureus in community hospitals. J Clin Microbiol (1984) 0.75
Impact of methicillin-resistant Staphylococcus aureus on treatment of hand infections. Eplasty (2009) 0.75
Pharmacokinetics and clinical use of cephalosporin antibiotics. J Pharm Sci (1975) 4.01
Penetration of amoxicillin, cefaclor, erythromycin-sulfisoxazole, and trimethoprim-sulfamethoxazole into the middle ear fluid of patients with chronic serous otitis media. J Infect Dis (1982) 3.96
Methicillin-resistant Staphylococcus aureus: introduction and spread within a hospital. Ann Intern Med (1980) 3.20
On the Gaseous Exchange of Ammonia between Leaves and the Environment: Determination of the Ammonia Compensation Point. Plant Physiol (1980) 2.94
Activity of minocycline against Acinetobacter calcoaceticus var. anitratus (syn. Herellea vaginicola) and Serratia marcescens. Antimicrob Agents Chemother (1975) 2.92
Species identification and susceptibility to 17 antibiotics of coagulase-negative staphylococci isolated from clinical specimens. J Clin Microbiol (1982) 2.58
Experience with a once-daily aminoglycoside program administered to 2,184 adult patients. Antimicrob Agents Chemother (1995) 2.49
Pharmacodynamic comparisons of levofloxacin, ciprofloxacin, and ampicillin against Streptococcus pneumoniae in an in vitro model of infection. Antimicrob Agents Chemother (1999) 2.06
Smoking cessation among self-quitters. Health Psychol (1992) 2.04
Time course of vasospasm in man. J Neurosurg (1978) 1.93
Intraoperative angiography in cerebral aneurysm surgery: a prospective study of 100 craniotomies. Neurosurgery (1996) 1.69
Comparison of bronchopulmonary pharmacokinetics of clarithromycin and azithromycin. Antimicrob Agents Chemother (1996) 1.68
Overwhelming sepsis associated with group A beta hemolytic streptococci. J Bone Joint Surg Am (1971) 1.66
Clinical laboratory comparison of lysis-centrifugation and BACTEC radiometric blood culture techniques. J Clin Microbiol (1983) 1.65
Gram-negative bacillary meningitis. Am J Med (1975) 1.64
Comparison of microdilution and broth dilution techniques for the susceptibility testing of yeasts to 5-fluorocytosine and amphotericin B. Antimicrob Agents Chemother (1979) 1.63
Development of meningitis during cephalothin therapy. Ann Intern Med (1973) 1.62
Significance of Staphylococcus epidermidis in the clinical laboratory. Appl Microbiol (1973) 1.61
Comparison of media and techniques for detection of group A streptococci in throat swab specimens. J Clin Microbiol (1979) 1.60
Pharmacokinetics and pharmacodynamics of total and unbound cefoxitin and cefotetan in healthy volunteers. J Antimicrob Chemother (1989) 1.55
In vitro antimicrobial susceptibility of glycopeptide-resistant enterococci. Diagn Microbiol Infect Dis (1995) 1.48
The penetration characteristics of cefazolin, cephalothin, and cephradine into bone in patients undergoing total hip replacement. J Bone Joint Surg Am (1977) 1.45
Combination antibiotic therapy: comparison of constant infusion and intermittent bolus dosing in an experimental animal model. J Antimicrob Chemother (1985) 1.44
Detection of bacteriuria by leukocyte esterase, nitrite, and the automicrobic system. Am J Clin Pathol (1984) 1.41
Absorption of vancomycin. Ann Intern Med (1984) 1.40
Regulation of VanA- and VanB-type glycopeptide resistance in enterococci. Antimicrob Agents Chemother (2001) 1.38
A pharmacodynamic model for the activity of antibiotics against microorganisms under nonsaturable conditions. J Pharm Sci (1986) 1.34
The association of bacteremic Haemophilus influenzae pneumonia in adults with typable strains. Am J Med (1971) 1.34
Management of acute subdural hematomas from aneurysmal rupture. Can J Neurol Sci (1984) 1.33
Bioavailability and pharmacokinetics of ofloxacin in healthy volunteers. Antimicrob Agents Chemother (1991) 1.33
Defective regulation of chemotaxis in cirrhosis. J Lab Clin Med (1975) 1.32
Microbial pharmacodynamics of piperacillin in neutropenic mice of systematic infection due to Pseudomonas aeruginosa. J Pharmacokinet Biopharm (1988) 1.32
Fibroblast growth factor-18 is a trophic factor for mature chondrocytes and their progenitors. Osteoarthritis Cartilage (2002) 1.29
End-to-end transcription of an Alu family repeat. A new type of polymerase-III-dependent terminator and its evolutionary implication. J Mol Biol (1985) 1.27
A common source outbreak of Acinetobacter pulmonary infections traced to Wright respirometers. Postgrad Med J (1980) 1.25
Trimethoprim-sulfamethoxazole for bacterial meningitis. Ann Intern Med (1984) 1.25
Evaluation of the efficacy of ciprofloxacin against Streptococcus pneumoniae by using a mouse protection model. Antimicrob Agents Chemother (1993) 1.25
Comparative efficacies of levofloxacin and ciprofloxacin against Streptococcus pneumoniae in a mouse model of experimental septicaemia. Int J Antimicrob Agents (1999) 1.24
Clinical experience on the detection of endotoxemia with the limulus test. J Infect Dis (1973) 1.24
Effect of protein binding on drug penetration into blister fluid. Antimicrob Agents Chemother (1988) 1.22
Flavobacterium meningosepticum meningitis in a newborn infant. Treatment with intraventricular erythromycin. J Pediatr (1974) 1.22
Synergism of cefazolin-gentamicin against enterococci. Antimicrob Agents Chemother (1976) 1.21
A multi-hospital hepatitis B vaccine program: prevalence of antibody and acceptance of vaccination among high-risk hospital employees. Infect Control (1985) 1.21
Aminoglycoside antibiotics moderately impair granulocyte function. Antimicrob Agents Chemother (1978) 1.20
The pharmacodynamics of aminoglycosides. Clin Infect Dis (1998) 1.18
A plea for clinical relevance in medical microbiology. Am J Clin Pathol (1974) 1.17
The osmolality of subdural hematoma fluid. J Neurosurg (1971) 1.17
Quality assurance of gram-stained direct smears. Am J Clin Pathol (1979) 1.16
Serum bactericidal activity of ceftazidime: continuous infusion versus intermittent injections. Antimicrob Agents Chemother (1996) 1.16
Bacteremic Pseudomonas pneumonia. JAMA (1974) 1.15
Allelic variants of aromatase and the androgen and estrogen receptors: toward a multigenic model of prostate cancer risk. Clin Cancer Res (2001) 1.15
Comparison of concentrations of amoxicillin and ampicillin in serum and middle ear fluid of children with chronic otitis media. J Infect Dis (1977) 1.14
First and second generation cephalosporins. Med Clin North Am (1982) 1.14
Continuous versus intermittent administration of ceftazidime in intensive care unit patients with nosocomial pneumonia. Int J Antimicrob Agents (2001) 1.13
Transmissible drug resistance of Escherichia coli and Salmonella from humans, animals, and their rural environments. J Infect Dis (1975) 1.12
Absence of IFNA and IFNB genes from human malignant glioma cell lines and lack of correlation with cellular sensitivity to interferons. Cancer Res (1990) 1.11
Reduction of bacterial titers by low-dose aspirin in experimental aortic valve endocarditis. Infect Immun (1993) 1.11
Mechanisms of glycopeptide resistance in enterococci. J Infect (1996) 1.10
Effect of protein binding on the penetration of nonmetabolized cephalosporins into atrial appendage and pericardial fluids in open-heart surgical patients. Antimicrob Agents Chemother (1980) 1.07
Prophylactic antibiotics in cholecystectomy. Lancet (1978) 1.07
Review of cefonicid, a long-acting cephalosporin. Clin Pharm (1984) 1.04
Minocycline versus vancomycin for treatment of experimental endocarditis caused by oxacillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother (1994) 1.04
Cost effectiveness of quality control in bacteriology. Am J Clin Pathol (1982) 1.04
Further observations on the antimicrobial effects of local anesthetic agents. Curr Ther Res Clin Exp (1975) 1.03
The management of .22 caliber gunshot wounds of the brain: a review of 49 cases. Can J Neurol Sci (1987) 1.03
Serratia marcescens bacteremia from contaminated pressure transducers. JAMA (1979) 1.03
The relative significance of factors affecting postoperative survival in astrocytomas, grades 3 and 4. J Neurosurg (1973) 1.03
Bacterial endocarditis caused by vitamin B6-dependent viridans group Streptococcus. Pediatrics (1980) 1.03
Once-daily aminoglycosides. Conn Med (1992) 1.02
Cellulitis due to Streptococcus pneumoniae: case report and review. Clin Infect Dis (1992) 1.01
Meningovascular syphilis after 'appropriate' treatment of primary syphilis. Arch Intern Med (1982) 1.01
Flavobacterium meningosepticum meningitis: report of selected aspects. Antimicrob Agents Chemother (1978) 1.01
Tuberous sclerosis. Surgical therapy for seizures. Arch Neurol (1966) 1.01
Treatment of nocardial infection with trimethoprim and sulfamethoxazole. Am J Med (1974) 1.00
Understanding HIV risks of chronic drug-using men who have sex with men. AIDS Care (1999) 1.00
Analytical variability in the single disk antimicrobial susceptibility test. Am J Clin Pathol (1973) 1.00
Oral bacitracin vs vancomycin therapy for Clostridium difficile-induced diarrhea. A randomized double-blind trial. Arch Intern Med (1986) 1.00
Contaminated breast milk: A source of Klebsiella bacteremia in a newborn intensive care unit. Rev Infect Dis (1982) 1.00
Treatment of prosthetic valve endocarditis due to methicillin-resistant Staphylococcus aureus with minocycline. J Infect Dis (1990) 0.99
Mycoplasma pneumoniae meningoencephalitis and transverse myelitis in association with low cerebrospinal fluid glucose. Pediatrics (1976) 0.99
Pharmacokinetics and penetration characteristics of cefazolin into human spinal fluid. Curr Ther Res Clin Exp (1976) 0.99
Penetration of cephapirin and cephalothin into the right atrial appendage and pericardial fluid of patients undergoing open-heart surgery. J Infect Dis (1979) 0.98
Effect of saturable serum protein binding on the pharmacokinetics of unbound cefonicid in humans. Antimicrob Agents Chemother (1986) 0.98
Clinical pharmacokinetics of newer cephalosporins. Clin Pharmacokinet (1995) 0.98
Vertebrobasilar junction aneurysms associated with fenestration: treatment with Guglielmi detachable coils. AJNR Am J Neuroradiol (1996) 0.97
Endocarditis from Serratia marcescens. JAMA (1969) 0.97
Clinical pharmacokinetics of ceftriaxone. Clin Pharmacokinet (1989) 0.97
Treatment and prevention of oropharyngeal candidiasis. Am J Med (1984) 0.97
Streptococcus pneumoniae response to repeated moxifloxacin or levofloxacin exposure in a rabbit tissue cage model. Antimicrob Agents Chemother (2001) 0.97
Pharmacodynamics and pharmacokinetics of levofloxacin. Chemotherapy (2000) 0.96
Pharmacokinetics of single- and multiple-dose teicoplanin in healthy volunteers. Antimicrob Agents Chemother (1989) 0.96
The morphology of the spike-wave complex. Electroencephalogr Clin Neurophysiol (1965) 0.96